Cargando…

Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits

PURPOSE: To evaluate the modifications of the tumor stage and clinical target volume following a prostate magnetic resonance imaging (MRI) to evaluate the tumor (T) staging, and the clinical benefits for prostate cancer. METHODS: A total of 410 patients with newly diagnosed and clinically localized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Shinsaku, Ohguri, Takayuki, Fujii, Masami, Yahara, Katsuya, Hayashida, Yoshiko, Fujimoto, Naohiro, Korogi, Yukunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502053/ https://www.ncbi.nlm.nih.gov/pubmed/26191474 http://dx.doi.org/10.1186/s40064-015-1138-9

Ejemplares similares

Cancer of the pelvis: definitive three-dimensional conformal radiotherapy for patients with isolated recurrence in the para-aortic lymph nodes
por: Yahara, Katsuya, et al.
Publicado: (2012)

Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy
por: Yahara, Katsuya, et al.
Publicado: (2013)

Salvage radiotherapy for second oligo-recurrence in patients with breast cancer
por: Miyata, Mari, et al.
Publicado: (2018)

Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time
por: Yamaguchi, Shinsaku, et al.
Publicado: (2013)

Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy
por: Fujii, Masami, et al.
Publicado: (2015)

Optimization of the Clinical Setting Using Numerical Simulations of the Electromagnetic Field in an Obese Patient Model for Deep Regional Hyperthermia of an 8 MHz Radiofrequency Capacitively Coupled Device in the Pelvis
por: Ohguri, Takayuki, et al.
Publicado: (2021)

Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma
por: Yahara, Katsuya, et al.
Publicado: (2017)

Pediatric nasopharyngeal cancer with repeated oligometastases involving the bone, liver and distant lymph nodes who achieved cure after radiotherapy
por: Ohguri, Takayuki, et al.
Publicado: (2020)

Intensity-Modulated Radiotherapy with Regional Hyperthermia for High-Risk Localized Prostate Carcinoma
por: Nakahara, Sota, et al.
Publicado: (2022)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
por: Tsuchida, Keisuke, et al.
Publicado: (2020)

Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference?
por: Viani, Gustavo, et al.
Publicado: (2019)

Echo response and clinical outcome in CRT patients
por: van ’t Sant, J., et al.
Publicado: (2015)

Peritumoral Fat Content Correlates with Histological Prognostic Factors in Breast Carcinoma: A Study Using Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-squares Estimation (IDEAL)
por: Hisanaga, Sachi, et al.
Publicado: (2020)

The effect of CT texture-based analysis using machine learning approaches on radiologists' performance in differentiating focal-type autoimmune pancreatitis and pancreatic duct carcinoma
por: Anai, Kenta, et al.
Publicado: (2022)

Correction to: The effect of CT texture‑based analysis using machine learning approaches on radiologists’ performance in differentiating focal‑type autoimmune pancreatitis and pancreatic duct carcinoma
por: Anai, Kenta, et al.
Publicado: (2022)

Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD
por: Nauffal, Victor, et al.
Publicado: (2017)

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited
por: Cremers, Ruben G., et al.
Publicado: (2016)

CRT-D or CRT-P in CRT-indicated patients?
por: Kaya, Adnan, et al.
Publicado: (2017)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

Clinical Utility of Body Surface Potential Mapping in CRT Patients
por: Sedova, Ksenia, et al.
Publicado: (2021)

The Role of Nuclear Receptors in Prostate Cancer
por: Shiota, Masaki, et al.
Publicado: (2019)

Prostate diseases and microbiome in the prostate, gut, and urine
por: Miyake, Makito, et al.
Publicado: (2022)

CRT-D or CRT-P?: the endless debate!
por: Daubert, J Claude
Publicado: (2023)

Risk of adverse pathological features for intermediate risk prostate cancer: Clinical implications for definitive radiation therapy
por: Zhang, Hong, et al.
Publicado: (2021)

The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
por: ter Horst, I. A. H., et al.
Publicado: (2016)

The Clinical Genetics of Prostate Cancer
por: Kommu, Sashi, et al.
Publicado: (2004)

Clinical Lectures on Enlargement of the Prostate
Publicado: (1921)

Multidisciplinary clinics in prostate cancer
por: De, Brian, et al.
Publicado: (2021)

Standardization of QRS Duration Measurement and LBBB Criteria in CRT Trials and Clinical Practice
por: Turagam, Mohit K, et al.
Publicado: (2013)

Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients
por: Russo, Vincenzo, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
por: Nepal, Sat Prasad, et al.
Publicado: (2023)

Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer
por: Shiota, Masaki, et al.
Publicado: (2021)

The influence of prostate volume on clinical parameters in prostate cancer screening
por: Shan, Jiahao, et al.
Publicado: (2022)

MET-04 EVALUATION OF PERITUMORAL BRAIN PARENCHYMA USING CONTRAST-ENHANCED FIESTA IMAGING FOR DIFFERENTIATING METASTATIC BRAIN TUMORS AND GLIOBLASTOMAS
por: Yamamoto, Junkoh, et al.
Publicado: (2019)

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
por: Oseni, Saheed Oluwasina, et al.
Publicado: (2023)

Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study
por: Dogan, Kazım, et al.
Publicado: (2022)

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions
por: Miyake, Makito, et al.
Publicado: (2019)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer
por: Thuret, R, et al.
Publicado: (2005)

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia
por: Cakir, Suleyman Sami, et al.
Publicado: (2018)

Assessment on clinical value of prostate health index in the diagnosis of prostate cancer
por: Zhang, Guangying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ooeef7k2i13svqeoe8rn9fquul